Chester County News and Community Website
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced a recent commercial agreement with Success TMS in which Success TMS will exclusively utilize Neuronetics’ platform, NeuroStar Advanced Therapy for Mental Health, …
Neuronetics Announces Commercial Agreement with Success TMS Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that a peer-reviewed paper showed significantly lower seizure risk with NeuroStar® Advanced Therapy for Mental Health than with TMS treatments that claim deeper …
New Data Highlights NeuroStar Advanced Therapy for Mental Health Safety Over H-Coil TMS Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that a peer-reviewed paper showed significantly lower seizure risk with NeuroStar® Advanced Therapy for Mental Health than with TMS treatments that claim deeper …
New Data Highlights NeuroStar Advanced Therapy for Mental Health Safety Over H-Coil TMS Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved the MicroTransponder Vivistim Paired VNS System (Vivistim System), a first-of-its-kind, drug-free rehabilitation system intended to treat moderate to severe …
FDA Approves First-of-Its-Kind Stroke Rehabilitation System Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer …
Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting Read More
Parkinson’s Disease (PD) impacts up to one in 15 individuals in the United States. People with PD often experience symptoms that impact their movement, like tremors, shuffling feet while walking, …
For Parkinson’s Disease Patients, Effective Implantable Therapy Can Now Last Up to 15 Years Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate …
FDA Authorizes Marketing of Device to Improve Gait in Multiple Sclerosis Patients Read More